Gilder Gagnon Howe & Co’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
MF
PCMI
AAM
AIC
WIC
Gilder Gagnon Howe & Co's NPTN Position: Q4 2021 in Review
Gilder Gagnon Howe & Co sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 180,083 shares — an estimated $1.57M sold.
Gilder Gagnon Howe & Co first reported a position in NPTN in Q3 2016 and held it in 16 quarters. The position peaked at $1.88M in Q2 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.
- Gilder Gagnon Howe & Co reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 180,083 NEOPHOTONICS CORP shares in Q4 2021, an estimated $1.57M.
- Gilder Gagnon Howe & Co first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 16 quarters.
- Gilder Gagnon Howe & Co's NEOPHOTONICS CORP position peaked at $1.88M in Q2 2021.
- 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.
Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.